추천 제품
Quality Level
분석
≥98% (HPLC)
양식
solid
색상
off-white
solubility
H2O: 19 mg/mL
주관자
Endo
SMILES string
CCC1=C(C)NC2=C1C(C(CN3CCOCC3)CC2)=O.Cl
InChI
1S/C16H24N2O2.ClH/c1-3-13-11(2)17-14-5-4-12(16(19)15(13)14)10-18-6-8-20-9-7-18;/h12,17H,3-10H2,1-2H3;1H
InChI key
GQWNECFJGBQMBO-UHFFFAOYSA-N
유전자 정보
human ... DRD2(1813) , HTR2A(3356) , MAOA(4128) , MAOB(4129)
유사한 제품을 찾으십니까? 방문 제품 비교 안내
생화학적/생리학적 작용
D2 dopamine receptor antagonist; MAO inhibitor.
특징 및 장점
This compound was developed by Endo. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
신호어
Danger
유해 및 위험 성명서
예방조치 성명서
Hazard Classifications
Acute Tox. 3 Oral
Storage Class Code
6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
WGK
WGK 3
Flash Point (°F)
Not applicable
Flash Point (°C)
Not applicable
개인 보호 장비
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
가장 최신 버전 중 하나를 선택하세요:
Jon McClellan et al.
Journal of the American Academy of Child and Adolescent Psychiatry, 46(8), 969-978 (2007-08-02)
The Treatment of Early Onset Schizophrenia Spectrum Disorders Study is a publicly funded clinical trial designed to compare the therapeutic benefits, safety, and tolerability of risperidone, olanzapine, and molindone in youths with early-onset schizophrenia spectrum disorders. The rationale, design, and
Treatment of morbidly obese psychotic patients with molindone: three case reports.
Robert E McCue et al.
The Journal of clinical psychiatry, 70(11), 1606-1607 (2009-12-25)
R B Rosse et al.
Clinical neuropharmacology, 19(5), 444-450 (1996-10-01)
This preliminary investigation examined the therapeutic efficacy of two doses of oral D-cycloserine (5 and 15 mg p.o. b.i.d.) administered as an adjuvant to molindone (150 mg p.o. q.d.) in the treatment of schizophrenia. D-Cycloserine is an agonist at the
M Froimowitz et al.
Drug design and discovery, 15(2), 63-81 (1997-08-01)
This study is an attempt to incorporate the butyrophenones, an important class of nontricyclic antipsychotic drugs, into a previously proposed pharmacophore model of tricyclic dopamine D2 receptor antagonist ligands. Conformational energy calculations were performed using the MM3-92 program on spiperone
The voices go, but the song remains the same: how can we rescue cognition in early-onset schizophrenia?
Peter Bachman et al.
Journal of the American Academy of Child and Adolescent Psychiatry, 51(5), 464-466 (2012-04-25)
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..
고객지원팀으로 연락바랍니다.